GeneCradle

Beijing, China · Founded 2018 · Privately Held (backing)

Developer of gene therapy drugs intended to treat rare diseases. GeneCradle is based in Beijing, China and was founded in 2018. Its last reported valuation was $288 million in Feb 2022. It has raised $61 million.

Last reported valuation

$287.8M

Oct 2026

Priced at

—

Total raised

$61.0M

Last round

—

How much has GeneCradle raised?

$61.0Macross 0 recorded rounds

Free account

More of GeneCradle with a free account

·Watch GeneCradle: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

GeneCradle investors

9 investors are on record for GeneCradle, including Shenzhen Capital Group, Oriental Fortune Capital, YuanBio Venture Capital and CASH Capital. By type, the record holds 4 venture capital firms and 1 asset manager.

For fundraisers

Raising for a company like GeneCradle?

9 investors have backed GeneCradle.

See all 9 investors →

Frequently asked about GeneCradle

How much has GeneCradle raised?: GeneCradle has raised $61.0M in total across 0 recorded funding rounds.